Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer

197.76
-2.59%
Ventura
Growth visibility with reasonable valuation
FII/FPI have increased holdings from 8.13% to 16.76% in Mar 2026 qtr.
More from Marksans Pharma L…
All earning calls
Investor presentations from Marksans Pharma L…
All investor presentations